XML 23 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net income $ 119,138,000 $ 121,274,000 $ 113,655,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation 20,847,000 19,509,000 18,698,000
Tax benefit from stock based compensation 0 0 (10,510,000)
Depreciation and amortization 21,389,000 21,102,000 20,757,000
Loss on disposal of fixed assets 1,455,000 652,000 1,780,000
Goodwill, Impairment Loss 1,000,000 0 3,045,000
Deferred taxes (19,274,000) (6,588,000) 7,271,000
Accrued interest on note receivable – related party (55) (63) (71)
Increase (Decrease) in Accrued Interest Receivable, Net 54,000 63,000 71,000
Repayment of Notes Receivable from Related Parties 409,000 409,000 409,000
Deferred rent expense 1,455,000 2,565,000 440,000
Loss (gain) on sale of marketable securities (5,000) 661,000 (67,000)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (11,206,000) (425,000) (5,576,000)
Provision for Doubtful Accounts 5,470,000 0 0
Changes in:      
Accounts receivable 22,683,000 (13,617,000) (11,071,000)
Due from factor (57,268,000) 11,043,000 7,281,000
Inventories 21,135,000 (17,744,000) (9,403,000)
Prepaid expenses, prepaid taxes, deposits and other 2,403,000 (3,461,000) 4,784,000
Accounts payable and accrued expenses 9,501,000 15,324,000 (8,643,000)
Accrued incentive compensation 2,507,000 1,819,000 468,000
Other liabilities 16,350,000 1,144,000 2,716,000
Net cash provided by operating activities 157,935,000 153,604,000 135,963,000
Cash flows from investing activities:      
Purchases of property and equipment (14,775,000) (15,897,000) (19,459,000)
Purchases of marketable securities (61,209,000) (40,451,000) (48,891,000)
Proceeds from Collection of Notes Receivable 221,000 249,000 466,000
Maturity/sale of marketable securities 79,141,000 52,215,000 43,353,000
Acquisitions (16,795,000) 0 (9,129,000)
Net cash used in investing activities (13,417,000) (3,884,000) (33,660,000)
Cash flows from financing activities:      
Proceeds from exercise of stock options 16,433,000 10,713,000 21,301,000
Payments to Acquire Businesses, Gross 0 (3,759,000) 0
Tax benefit from the exercise of options 0 0 10,510,000
business combinations contingent liability payment (7,359,000) (16,402,000) (6,270,000)
Common stock purchased for treasury (99,412,000) (86,005,000) (135,637,000)
Net cash provided by financing activities (90,338,000) (95,453,000) (110,096,000)
Effect of Exchange Rate on Cash and Cash Equivalents 919,000 (566,000) (1,243,000)
Net decrease in cash and cash equivalents 55,099,000 53,701,000 (9,036,000)
Cash and cash equivalents – beginning of period 126,115,000 72,414,000 81,450,000
Cash and cash equivalents – end of period 181,214,000 126,115,000 72,414,000
Cash paid during the year for:      
Interest 24,000 222,000 328,000
Income taxes $ 61,979,000 $ 55,384,000 $ 39,424,000